Maternal plasma leptin concentration is significantly increased during pregnancy. However, its roles in pregnancy, especially in labor, have not been fully clarified. We measured plasma leptin concentrations in pregnant women during the course of induced labor, just after spontaneous vaginal delivery and Cesarean section at term. We also studied the regulation of leptin secretion from term placental tissue and BeWo cells, a trophoblastic cell-line. Plasma leptin concentrations increased significantly during labor (58.9 ± 9.2 ng/ml) compared to those before labor induction (37.5 ± 5.8 ng/ml, P<0.05), then decreased 3-6 days postpartum (14 ± 3 ng/ml, n = 6, P<0.0001) to the levels of normal nonpregnant women. Leptin concentrations within an hour and 24 hours after spontaneous vaginal delivery were significantly higher than those after Cesarean section (P<0.05 for both comparisons). Similarly, leptin mRNA expression in placental tissues obtained after spontaneous vaginal delivery was significantly greater than that in those obtained after Cesarean section without labor (P<0.05). IL-1a and TNF-a treatment significantly stimulated leptin secretion and leptin mRNA expression in explant culture of human term placental tissue and in BeWo cells as compared with those in vehicle controls (P<0.05, for all comparisons). By contrast, oxytocin and prostaglandin F 2a treatment had no effects on leptin secretion from explant culture of human term placental tissue or from BeWo cells. These data indicate that proinflammatory cytokines might stimulate placental leptin secretion, thus finally contributing to the increase in plasma leptin concentration during labor.
LEPTIN, the obese (ob) gene product, is a 16 kD peptide hormone produced abundantly in adipose tissue and human placental trophoblasts [1, 2] . Plasma leptin concentration increases significantly during pregnancy as masses of adipose tissue and placenta increase and it decreases dramatically after removal of the placenta, thereby suggesting a major contribution of the placenta [2] [3] [4] . Leptin plays important roles in energy metabolism and in reproduction. For instance, mice with mutation in the ob gene exhibit reduced activity, metabolism, and body temperature, which are restored with daily injection of recombinant leptin [5] . Fertility defect in homozygous obese female mice (ob/ob mice) is treated with recombinant leptin [6] . In addition, recent studies from our laboratory have shown that female transgenic skinny mice overexpressing leptin, exhibit accelerated puberty and intact fertility at a younger age [7] . Recent reports have also shown that leptin has other pleiotrophic peripheral actions such as neovascularization, wound healing and immunomodulation. However, the ability to stimulate energy me-tabolism is thought to be the central function of leptin [8] [9] [10] [11] .
During labor, maternal energy requirement increases during active uterine contraction. Fetal energy metabolism may also be influenced by labor. Thus, it is plausible that placental leptin may play some roles in the energy metabolism of both mother and fetus during labor. However, previous studies on placental leptin have been limited to maternal leptin concentrations [2, 4, [12] [13] [14] .
Several experimental studies have shown that production of leptin is regulated by a variety of factors, including inflammation, presence of other hormones and cytokines [15] [16] [17] . Some changes in the pregnant uterus during labor partly resemble those of inflammation from the perspective of augmented production of pro-inflammatory cytokines such as interleukin 1a (IL-1a) and TNFa. Placental production of both IL-1a and TNFa are reported to be elevated in labor [18, 19] . However, the effect of IL-1a and TNFa on leptin secretion from placental tissue has not been fully clarified.
Recently, we have demonstrated that free-to-total leptin ratio in maternal plasma remains constant throughout human pregnancy despite the significant increase in leptin concentrations [20] . However, the effect of labor on free-to-total leptin ratio has yet to be determined. In the present study, we examined maternal plasma leptin concentrations before and during induction of labor at term. Therefore, the objectives of the present study are to clarify whether; 1) maternal plasma leptin concentrations as well as free-to-total ratio alter during induced labor, 2) IL-1a or TNFa affect leptin secretion and leptin mRNA expression in term placental tissue or BeWo cells, a trophoblastic cell line, and 3) whether oxytocin and prostaglandin F 2a affect leptin secretion from term placental tissue or BeWo cells.
Materials and Methods

Reagents
All reagents were of analytical grade and purchased from Nacalai Tesque Inc. (Kyoto, Japan) unless otherwise indicated.
Materials and Subjects
Blood specimens were drawn from the antecubital vein of six pregnant women during the course of labor induction at term (26.3 ± 1.6 [SEM] y. o.; 38-41 weeks of gestation) and from six pre-menopausal nonpregnant women (39.0 ± 2.6 y. o.). Maternal blood samples were consecutively taken before induction, during active labor and at 3-6 days postpartum. Labor was induced in these pregnant women because active uterine contraction did not commence within 24 hours after spontaneous rupture of the membrane. Labor was induced in two patients by oxytocin infusion, in two patients by prostaglandin F 2a (PGF 2a ) infusion, in one patient by oxytocin and then PGF 2a on the following day, and in the last patient by PGF 2a infusion then prostaglandin E 2 (PGE 2 ) medication on the following day. Mechanical cervical dilatation using devices such as laminaria was not carried out in any cases. Blood samples were also taken from 11 women after spontaneous vaginal delivery of singleton (30.3 ± 3.7 y. o.; 38-41 weeks of gestation) and 8 women after Cesarean section (30.1 ± 1.1 y. o.; 37-39 weeks of gestation). Samples were transferred immediately into chilled siliconized glass tubes containing sodium ethylenediaminetetraacetatic acid (1 mg/ml) and aprotinin (1,000 units/ ml), and centrifuged at 3,000 × g for 5 minutes at 4°C. Plasma samples thus obtained were stored at -20°C until use. For in vitro experiments, placental tissues at term were obtained under aseptic conditions from fifteen women after spontaneous vaginal delivery of singleton (30.3 ± 1.1 y. o.; 38-41 weeks of gestation) and from seven pregnant women after Cesarean delivery (33.5 ± 1.8 y. o.; 37-38 weeks of gestation). These samples were immediately used in explant culture experiments. There was no clinical evidence of intrauterine infection in any of the women during the course of delivery. None of the women had preeclampsia, diabetes mellitus or any other neuroendocrine disease before or during pregnancy. Informed consent was obtained from each participant before enrolling in the study. The study was approved by the Ethics Committee on human research of Kyoto University Graduate School of Medicine.
Determination of leptin concentrations
Leptin concentrations in plasma samples and culture media were determined by a radioimmunoassay (RIA) specific for human leptin as previously reported [21] . The detection limit of this assay was 1.0 ng/ml for plasma and 0.5 ng/ml for culture medium. Inter-and intra-assay variations were 5.9% and 5.3%, respectively.
Determination of percent free leptin
Gel permeation chromatography of leptin was performed as previously described with slight modifications [20, 22] . Briefly, plasma samples (200 ml) were fractionated on a Sephacryl S-200 gel filtration column with phosphate buffered saline (PBS), containing 0.01% sodium azide (NaN 3 ). The elution positions of the void volume and free leptin were determined by loading the column with blue dextran and recombinant leptin, respectively. We employed an alternative method of calculating the leptin binding capacity in the plasma. We incubated plasma with 125 I labeled leptin (~5,000 cpm, specific activity was 0.11 mCi/mg leptin) overnight before fractionation with Sephacryl S-200 gel filtration column. Radioactivity of each fraction was counted after gel filtration [20] . Distribution of the radioactivity was almost the same as that of leptin determined by ELISA. Thus, we used the radioactivity to calculate the percent free leptin. Bound leptin representing 125 I-leptin complex with macromolecule(s) corresponds to the radioactivity eluting in the void volume, whereas free leptin represents radioactivity eluting at the position of the recombinant leptin region. Percent free leptin was calculated after gel permeation chromatography by dividing the amount of free leptin or radioactivity eluted in the position for recombinant free leptin by total leptin eluted as previously described [20, 22] .
Determination of soluble leptin receptor concentrations
Plasma soluble leptin receptor concentrations were measured using a commercially available human leptin receptor ELISA kit according to the manufacturer's recommendation (BioVendor Laboratory Medicine Inc., Brno, Czech Republic).
Explant culture of human placental tissue at term
Explant culture of human placental tissues at term was performed as described previously [23] with slight modifications. Briefly, placental tissues were sampled from several different parts of the placenta after amniotic membrane and maternal decidual tissue were removed. Tissues were mixed together, rinsed with PBS and minced into 1-to 2-mm pieces. Approximately 200 mg term placental tissue was dispersed per well in 12-well collagen-coated dishes with 0.5 ml RPMI 1640 (Gibco BRL, Gaithersburg, MD) supplemented with 10% FCS, penicillin (100 U/ml) and streptomycin (100 mg/ml), and cultured under humidified and 5% CO 2 balanced air at 37°C (day 0). After 48 hours preincubation (day 2), medium was replaced with fresh RPMI including 10% FCS with or without interleukin-1a (IL-1a) (a generous gift from Dai Nippon Pharmaceutical Company Co., Osaka, Japan), tumor necrosis factor a (TNF-a), oxytocin (OXT) (Peptide Institute Inc., Osaka, Japan) or prostaglandin F 2a (PGF 2a ). Medium was sampled and stored at -20°C after 6, 12 and 24 hours incubation with IL-1a or TNFa treatment (day 3). Leptin secretion was determined by measuring its concentrations in culture medium with RIA [2, 21] .
Culture of BeWo cells
BeWo cells were cultured as previously described with slight modifications [2, 24] . In brief, cells were cultured in 3.5 cm collagen-coated dishes at a concentration of 2 × 10 5 cells ml -1 in RPMI 1640 containing 10% FCS. At confluence (day 0), the culture medium was replaced with fresh RPMI including 10% FCS and forskolin (10 mM) with or without stimulation by IL-1a, TNF-a, OXT or PGF 2a . Forskolin was used to facilitate syncytial formation in BeWo cells as a model to study leptin secretion from syncytiotrophoblast cells in the term placental tissues [2, 23] . Medium was sampled and stored at -20°C after 12, 24 and 48 hours incubation (day 1-2). Leptin secretion was determined by measuring its concentrations in culture medium with RIA [2, 21] .
Quantitative RT-PCR analysis of leptin mRNA expression in BeWo cells
RNA was extracted from BeWo cells [2] . Quantitative RT-PCR analysis of leptin mRNA expression was carried out using Taq Man technology as previously described [25] . Forward and reverse primers and Fam/ Tamra or Joe/Tamra-labeled probes used for amplification of part of the human leptin and human GAPDH were: leptin forward: 5'-CCAAAACCCTCATCAAG ACAATT-3'; leptin reverse: 5-GAATGAAGTCCAA ACCGGTGA-3'; leptin (Fam/Tamra) probe: 5'-Fam-CACGCAGTCAGTCTCCTCCAAACAGAAA-Tamra-3'; GAPDH forward: 5'-GAAGGTGAAGGTCGGAGT-3'; GAPDH reverse: 5'-CTTCTACCACTACCCTAAA G-3'; and GAPDH (Joe/Tamra) probe: 5'-Joe-CCGAC TCTTGCCCTTCGAAC-Tamra-3'. Cycling parameters used were 2 min at 50°C, 30 s at 60°C, and 5 min at 95°C, followed by 40 cycles of 20 s at 94°C and 1 min at 60°C. The human leptin mRNA expression was estimated by dividing the leptin C T values by the GAPDH C T values as previously described (25) .
Statistical analysis
Leptin concentrations were distributed lognormal. Differences between groups were evaluated by Mann-Whitney U-test for comparison of two groups, or analysis of variance (ANOVA) with Fisher's least significant difference test for comparison of three or more groups. All values were expressed as the mean ± SEM. P values less than 0.05 were regarded as significant.
Results
Plasma leptin concentrations in pregnant women with induced labor
Plasma leptin concentrations of all the pregnant women increased significantly during labor to the level of 58. 9 ± 9.2 ng/ml (mean ± SEM, n = 6) compared to those before induction (37.5 ± 5.8 ng/ml, P<0.05), then decreased 3-6 days postpartum (14.2 ± 3.2 ng/ml, P<0.0001) to the level of nonpregnant women with the same BMI (20.3 ± 4.5 ng/ml, n = 6) ( Fig. 1) . A significant elevation (165 ± 16%; range, 114%-216%) and a rapid decline in leptin concentration was observed within this short time period between labor induction and postpartum in all the patients irrespective of the form of treatment received (OTX; n = 2, PGF 2a ; n = 2, both OTX and PGF 2a ; n = 1, or PGF 2a and PGE 2 ; n = 1). (20) . Samples before induction (A), during labor (B) and in the postpartum period (C) had three peaks. The first was around the void volume (Vo), calibrated with blue dextran and the third was at the elution position of recombinant leptin, 125 I-leptin region (Re). Bound leptin representing 125 I-leptin complex with macromolecules corresponds to radioactivity in the first and second peaks. Free leptin corresponds to radioactivity eluting in the 125 I-leptin region (Re) in the third peak (Fig. 2) . The percent free leptin in the maternal plasma was constant throughout induced delivery (before induction, during labor and early postpartum, 3-6 days, Fig. 3A ) despite the significant increase in maternal plasma leptin concentrations in labor (Fig. 1) . Plasma soluble leptin receptor concentrations also remained unchanged during induced delivery, and slightly decreased on the 3rd-6th postpartum days, but the changes were not significant ( Fig. 3B ).
Percent free leptin and soluble leptin receptor concentrations in maternal plasma
Effect of labor on maternal plasma leptin concentrations and leptin mRNA expression in placental tissue
Leptin concentrations within an hour and 24 hours after spontaneous vaginal delivery (45.2 ± 24.7, 41.3 ± 19.8 ng/ml n = 11, respectively) were significantly higher than those after Cesarean section (21.0 ± 3.7, 12.5 ± 4.2 ng/ml n = 8, respectively, P<0.05 for both comparisons) ( Fig. 4 ). Leptin mRNA expression (leptin/GAPDH) in placental tissues obtained after spontaneous vaginal delivery (0.3220 ± 0.0854AU, n = 10) was significantly (P<0.05) greater than that in those obtained after Cesarean section without labor (0.1058 ± 0.0517AU, n = 4) ( Fig. 5 ).
Effect of IL-1a treatment on leptin secretion from explant placental tissue and BeWo cells
IL-1a treatment (1, 2, 3 ng/ml) dose-dependently stimulated leptin secretion from explant cultures of both term placental tissue (Table 1A) and BeWo cells (Table 1B) . Leptin secretion into the culture medium from explant culture of term placental tissue under stimulation with 3 ng/ml IL-1a treatment for 12 hours (7.7 ± 2.4 ng/g wet tissue) was 197% higher than that of vehicle-treated placental tissue (3.9 ± 0.9 ng/g wet tissue). After 24 hours of stimulation, leptin secretion was 23.9 ± 3.9 ng/g wet tissue, which was significantly higher (368%) than that of vehicle-treated control at the same time (6.5 ± 1.9 ng/g wet tissue, P<0.01) (Fig. 6A) . Similarly, leptin secretions into the culture medium from BeWo cells under stimulation with 3 ng/ml IL-1a treatment for 24 and 48 hours were 2.6 ± 0.1 ng/10 6 cells and 4.4 ± 0.3 ng/10 6 cells, respectively. They were also significantly higher (120% and 163%) than those from vehicle-treated controls (2.1 ± 0.1 ng/10 6 cells and 2.7 ± 0.3 ng/10 6 cells, P<0.05 and P<0.01), respectively (Fig. 6B ).
Effect of TNF-a treatment on leptin secretion from explant placental tissue and BeWo cells
TNF-a treatment (1, 10, 30 ng/ml) dose dependently stimulated leptin secretion from explant cultures of both term placental tissue (Table 2A ) and BeWo cells (Table 2B) . Leptin secretion into the culture medium from explant culture of term placental tissue under stimulation with 10 ng/ml TNF-a for 24 hours was 15.3 ± 0.8 ng/g wet tissue, which was significantly higher than that from vehicle-treated control (8.7 ± 1.0 ng/g wet tissue, P<0.05) (Fig. 7A) . Similarly, leptin secretions into the culture medium from BeWo cells under stimulation with 10 ng/ml TNF-a treatment for 24 and 48 hours (2.3 ± 0.1 ng/10 6 cells and 3.9 ± 0.2 ng/10 6 cells) were significantly higher than those from vehicle-treated controls (1.8 ± 0.2 ng/10 6 cells and 3.2 ± 0.1 ng/10 6 cells, P<0.05 for both), respectively (Fig. 7B) .
Effect of IL-1a or TNF-a treatment on leptin messenger RNA (mRNA) expression in BeWo cells
Leptin mRNA expressions in BeWo cells after 24 hours incubation with IL-1a (3 ng/ml) or TNF-a (10 ng/ml) were 0.00059 ± 0.0001 AU (leptin/GAPDH) (n = 5) and 0.00051 ± 0.00002 AU (leptin/GAPDH) (n = 5), respectively, both of which were significantly higher than that of vehicle control 0.00037 ± 0.00004 AU (leptin/GAPDH) (n = 5; P<0.05 for both) (Fig 8) .
Effect of OXT or PGF 2a treatment on leptin secretion from explant placental tissue and BeWo cells
OXT treatment (0.1, 1, 10 mM) did not show any significant effect on leptin secretion from explant culture of term placental tissue (Table 3A) or from BeWo cells (Table 3B ). PGF 2a treatment (0.1, 1, 10 mM) had no significant effect on leptin secretion either from explant culture of term placental tissue (Table 3A) or from BeWo cells (Table 3B ).
Discussion
We previously reported that plasma leptin concentration increases significantly during pregnancy and decreases in the postpartum, suggesting a role for leptin in gestation [2] . The present longitudinal study demonstrated that plasma leptin concentration increased further in induced labor (Fig. 1 ). Measurement at three points (before induction, during labor and in the early postpartum) in the same women demonstrated a significant increase in leptin concentration in maternal plasma during advanced labor and a decrease in the early postpartum period. These findings led us to speculate that labor influenced the production of leptin in the placenta, which may be the main contributor of leptin in maternal circulation.
In the present study, labor was induced by OXT infusion, PGF 2a infusion, or both, all of which had similar effects on plasma leptin concentrations. However, oxytocin and prostaglandin F 2a treatment had no significant effect on leptin secretion from cultured trophoblast cells (Table 3 ). This implies that the agents used in induction may not have a direct effect on the increase in leptin concentration observed during labor. Unfortunately, we could not compare plasma leptin concentrations in the course of spontaneous labor because blood specimens were not collected several hours before spontaneous onset of labor. However, the finding that plasma leptin concentrations at one and 24 hours after spontaneous vaginal deliveries were significantly higher than those at the same times after Cesarean section without labor leads us to speculate that leptin secretion from the placenta is augmented by labor and results in an increase in plasma leptin concentrations in normal delivery. Yoshimitsu et al.
reported augmented placental leptin release during advanced labor based on higher umbilical venous and arterial blood leptin concentrations in the vaginal delivery group compared with the Cesarean group [26] . Although leptin secretion into umbilical circulation accounts for only a small percentage of leptin produced in the placenta, this finding supports the possibility that placental leptin production increases during labor [27] . Gel filtration profiles of maternal plasma leptin showed three peaks that remained stable during labor (Fig. 2) . The first two are considered bound leptin and the last is considered free leptin (20) . Percent free leptin remained constant during labor, despite a significant elevation in plasma leptin concentration (Fig. 3) . However, soluble leptin receptor concentration did not change during labor, despite the increase in leptin concentration and constant percentage free leptin. Taken together, these suggest that production of leptin binding proteins may be elevated during labor. However, further characterization of leptin binding proteins especially during labor would be necessary to confirm such a speculation.
Biochemical and physiological events that occur during labor partly resemble those in inflammatory reaction including the enhanced production of proinflammatory cytokines such as interleukin 1a (IL-1a). For instance, IL-1a is said to signal the onset of labor, while labor enhances placental production of interleukins [18, 19] . IL-1 stimulates leptin secretion in placental trophoblasts and induces its production in adipose tissue [17, 28] . TNF-a has also been shown to stimulate release of preformed leptin from adipose tissue and subsequently suppress its production [29, 30] . However, the effects on trophoblast leptin secretion have yet to be fully clarified. The present study demonstrated that both IL-1a and TNF-a significantly stimulated leptin secretion from term placental tissue and BeWo cells in a dose-(Tables 1 and 2) and timedependent manner ( Figs. 6 and 7) , although dosedependent effect of IL-1a treatment was observed in a rather limited range of IL-1a concentrations (1-3 ng/ml) ( Table 1 ) [17] . Leptin mRNA expression in BeWo cells, a trophoblastic cell line, was significantly up-regulated by treatment with these cytokines (Fig. 8) . Taken together, it is plausible that pro-inflammatory cytokines may at least partly contribute to an increase in maternal plasma leptin concentrations during induced labor through augmentation of placental leptin mRNA expression. The possible contribution of adipose tissue leptin to the elevated plasma leptin during labor is an interesting topic for future study.
The physiological significance of elevated plasma leptin concentrations during pregnancy and labor is not well understood. Firstly, the energy requirement is in- creased in pregnant women in order to provide metabolical support for the growing fetus [31] , and further increases after the onset of labor. From this perspective, the increase in maternal plasma concentration of leptin with functions, such as a feedback signal to the satiety center from body fat stores, is not beneficial during pregnancy. Clinically, maternal appetite during pregnancy is not suppressed despite the increased leptin concentration [32] . Maternal food intake is usually reduced after the onset of active labor, which is compatible with the satiety effect by elevated leptin concentration. At present, we do not have a clear explanation of such different effects of elevated leptin concentration in pregnant women. One possibility may be that a gradual increase in leptin concentration and chronic hyperleptinemia may reduce the sensitivity of the satiety center to leptin, but that the center may respond to a further increase in leptin during labor. On the other hand, leptin promotes mobilization of energy from adipose tissue to peripheral organs, and stimulates energy utilization in these peripheral organs [33] . It also promotes utilization of glucose in peripheral organs including muscle [34] . Elevated maternal leptin concentration during labor may, therefore, be beneficial for maternal energy utilization in maintaining vigorous myometrial contraction during labor. Secondly, peripheral functions of leptin, such as suppression of inflammatory reaction and promotion of wound reepithelialization, are also reported [9] . Elevated maternal leptin concentration during labor might there-fore contribute to the remodeling of intrauterine tissues after delivery. In summary, this report is to our knowledge the first on the effect of labor on maternal plasma leptin concentration. Longitudinal evidence has been presented showing increased leptin concentrations with a constant percent of free leptin and soluble leptin receptor concentration during induced labor. We have also shown that IL-1a and TNF-a up-regulate leptin mRNA expression and thereby may modulate leptin production from the placenta. This may contribute to an increase in plasma leptin concentration during induced labor. However, oxytocin and prostaglandin F 2a used in the induction of labor had no significant effect on leptin secretion from placental trophoblasts. The physiological significance of leptin in labor is an important focus for our future study.
